亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欢呼鼠标完成签到,获得积分10
刚刚
科研通AI6.2的应助被dd采纳,获得10
3秒前
酷酷云朵完成签到,获得积分10
4秒前
隐形曼青的应助被zhujh采纳,获得10
9秒前
13秒前
13秒前
x夏天完成签到 ,获得积分10
13秒前
玩命的芸遥完成签到,获得积分10
14秒前
简单一江完成签到,获得积分10
15秒前
19秒前
19秒前
YY完成签到,获得积分10
21秒前
zhujh完成签到,获得积分10
21秒前
Sophia完成签到 ,获得积分10
21秒前
23秒前
petrichor发布了新的文献求助10
25秒前
eily发布了新的文献求助10
25秒前
科研通AI6.4的应助被dd采纳,获得10
27秒前
28秒前
30秒前
安静皮带发布了新的文献求助10
32秒前
小鱼完成签到 ,获得积分10
32秒前
算命的完成签到,获得积分10
34秒前
wvs完成签到 ,获得积分10
34秒前
35秒前
41秒前
42秒前
45秒前
eily发布了新的文献求助30
45秒前
dd发布了新的文献求助10
45秒前
petrichor发布了新的文献求助10
46秒前
天天天晴完成签到 ,获得积分0
49秒前
53秒前
橘子侠完成签到 ,获得积分10
55秒前
58秒前
眼睛大乐巧完成签到 ,获得积分10
1分钟前
1分钟前
sweetpotato完成签到 ,获得积分10
1分钟前
执着访云完成签到,获得积分10
1分钟前
1分钟前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Organizational Behavior 510
Arbitrage Theory in Discrete and Continuous Time 500
English Longitudinal Study of Ageing: Waves 0-11, 1998-2024 300
2026-2030年中國基因檢測行業市場前瞻與未來投資戰略分析報告 300
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7828062
求助须知:如何正确求助?哪些是违规求助? 9353361
关于积分的说明 20572839
捐赠科研通 7420981
什么是DOI,文献DOI怎么找? 3335718
关于科研通互助平台的介绍 2480551
邀请新用户注册赠送积分活动 2356205